Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Gruberg

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
The American Journal of Cardiology|January 10, 2002
Comparison of outcomes after percutaneous coronary revascularization with stents in patients with and without mild chronic renal insufficiencyLuis Gruberg, Neil J Weissman, Ron Waksman, et al.
The American Journal of Cardiology|February 8, 2005
Impact of body mass index on the outcome of patients with multivessel disease randomized to either coronary artery bypass grafting or stenting in the ARTS trial: The obesity paradox II?Luis Gruberg, Nestor Mercado, Simcha Milo, et al.
Journal of the American College of Cardiology|February 19, 2002
The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox?Luis Gruberg, Neil J Weissman, Ron Waksman, et al.
Journal of Interventional Cardiology|September 25, 2012
Sustained low clinical event rates in real-world patients receiving everolimus-eluting coronary stent system from a large, prospective, condition of approval study: 2-year clinical outcomes from the XIENCE V USA StudyJames B Hermiller, David R Rutledge, Luis Gruberg, et al.
Circulation|July 3, 2002
Stroke complicating percutaneous coronary interventions: incidence, predictors, and prognostic implicationsShmuel Fuchs, Eugenio Stabile, Timothy D Kinnaird, et al.
JACC. Cardiovascular Interventions|December 24, 2011
A new era of prospective real-world safety evaluation primary report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System condition-of-approval post-market study)Mitchell W Krucoff, David R Rutledge, Luis Gruberg, et al.
JACC. Cardiovascular Interventions|October 26, 2019
Blinded Physiological Assessment of Residual Ischemia After Successful Angiographic Percutaneous Coronary Intervention: The DEFINE PCI StudyAllen Jeremias, Justin E Davies, Akiko Maehara, et al.
The American Journal of Cardiology|December 17, 2011
Comparison of late results of percutaneous coronary intervention among stable patients ≤65 versus >65 years of age with an occluded infarct related artery (from the Occluded Artery Trial)Adam H Skolnick, Harmony R Reynolds, Harvey D White, et al.
The American Journal of Cardiology|January 31, 2007
Protection of Distal Embolization in High-Risk Patients with Acute ST-Segment Elevation Myocardial Infarction (PREMIAR)Fernando A Cura, Alejandro Garcia Escudero, Daniel Berrocal, et al.
JACC. Cardiovascular Interventions|January 7, 2022
1-Year Outcomes of Blinded Physiological Assessment of Residual Ischemia After Successful PCI: DEFINE PCI TrialManesh R Patel, Allen Jeremias, Akiko Maehara, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
The American Journal of Cardiology|January 10, 2002
Comparison of outcomes after percutaneous coronary revascularization with stents in patients with and without mild chronic renal insufficiencyLuis Gruberg, Neil J Weissman, Ron Waksman, et al.
The American Journal of Cardiology|February 8, 2005
Impact of body mass index on the outcome of patients with multivessel disease randomized to either coronary artery bypass grafting or stenting in the ARTS trial: The obesity paradox II?Luis Gruberg, Nestor Mercado, Simcha Milo, et al.
Journal of the American College of Cardiology|February 19, 2002
The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox?Luis Gruberg, Neil J Weissman, Ron Waksman, et al.
Journal of Interventional Cardiology|September 25, 2012
Sustained low clinical event rates in real-world patients receiving everolimus-eluting coronary stent system from a large, prospective, condition of approval study: 2-year clinical outcomes from the XIENCE V USA StudyJames B Hermiller, David R Rutledge, Luis Gruberg, et al.
Circulation|July 3, 2002
Stroke complicating percutaneous coronary interventions: incidence, predictors, and prognostic implicationsShmuel Fuchs, Eugenio Stabile, Timothy D Kinnaird, et al.
JACC. Cardiovascular Interventions|December 24, 2011
A new era of prospective real-world safety evaluation primary report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System condition-of-approval post-market study)Mitchell W Krucoff, David R Rutledge, Luis Gruberg, et al.
JACC. Cardiovascular Interventions|October 26, 2019
Blinded Physiological Assessment of Residual Ischemia After Successful Angiographic Percutaneous Coronary Intervention: The DEFINE PCI StudyAllen Jeremias, Justin E Davies, Akiko Maehara, et al.
The American Journal of Cardiology|December 17, 2011
Comparison of late results of percutaneous coronary intervention among stable patients ≤65 versus >65 years of age with an occluded infarct related artery (from the Occluded Artery Trial)Adam H Skolnick, Harmony R Reynolds, Harvey D White, et al.
The American Journal of Cardiology|January 31, 2007
Protection of Distal Embolization in High-Risk Patients with Acute ST-Segment Elevation Myocardial Infarction (PREMIAR)Fernando A Cura, Alejandro Garcia Escudero, Daniel Berrocal, et al.
JACC. Cardiovascular Interventions|January 7, 2022
1-Year Outcomes of Blinded Physiological Assessment of Residual Ischemia After Successful PCI: DEFINE PCI TrialManesh R Patel, Allen Jeremias, Akiko Maehara, et al.
Pageof 13